Novel anti-staphylococcal targets and compounds.

about

Biological properties of novel antistaphylococcal quinoline-indole agents.Antibiotic resistance in Staphylococcus aureus: concerns, causes and cures.MRSA--what is it, and how do we deal with the problem?

P2860

Q34821242-C6835217-9489-4A7C-8E20-6B9795602BAA Q35917130-0E1E3BCF-3187-45CC-BA0C-564F3CA0C4D8 Q36150828-245E47AC-D872-4C0B-8469-15AD37336D0E

P2860

Novel anti-staphylococcal targets and compounds.

Item

http://www.wikidata.org/entity/Q53852773

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

1998年學術文章

@zh-hant

name

Novel anti-staphylococcal targets and compounds.

@en

Novel anti-staphylococcal targets and compounds.

@nl

type

Item

label

Novel anti-staphylococcal targets and compounds.

@en

Novel anti-staphylococcal targets and compounds.

@nl

prefLabel

Novel anti-staphylococcal targets and compounds.

@en

Novel anti-staphylococcal targets and compounds.

@nl

P1476

Novel anti-staphylococcal targets and compounds.

@en

P2093

Ehlert K

http://www.w3.org/2001/XMLSchema#string

Labischinski H

http://www.w3.org/2001/XMLSchema#string

Wieland B

http://www.w3.org/2001/XMLSchema#string

P2860

The crisis in antibiotic resistance.

Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control.

Cloning and expression of methicillin resistance from Staphylococcus epidermidis in Staphylococcus carnosus.

Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in Staphylococcus aureus.

Construction of a modified penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus and purification by immobilized metal affinity chromatography.

Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus

TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus

The worldwide prevalence of methicillin-resistant Staphylococcus aureus.

An Enzyme from Bacteria able to Destroy Penicillin

Binding of beta-lactam antibiotics to penicillin-binding proteins in methicillin-resistant Staphylococcus aureus.

P304

1245-1256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.7.8.1245

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1998-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15992028

http://www.w3.org/2001/XMLSchema#string

Novel anti-staphylococcal targets and compounds.

about

P2860

P2860

Novel anti-staphylococcal targets and compounds.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698